Happy for the patients, company and SHs.
Just curious what could be the uptake in Australia where Folforinox is not SOC for Pancreatic cancer? Isn’t that why this was supposed to be an US centric trial?
- Forums
- ASX - By Stock
- ATX
- Ann: AUSTRALIAN TRIAL SITES OPEN FOR NEW NARMAFOTINIB TRIAL
ATX
amplia therapeutics limited
Add to My Watchlist
10.7%
!
12.5¢
Ann: AUSTRALIAN TRIAL SITES OPEN FOR NEW NARMAFOTINIB TRIAL, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.